- Home
- CLLS vs PERF Comparison
CLLS vs PERF Comparison
Compare CLLS & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- PERF
- Stock Information
- Founded
- CLLS 1999
- PERF 2015
- Country
- CLLS France
- PERF Taiwan
- Employees
- CLLS N/A
- PERF N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- PERF Computer Software: Prepackaged Software
- Sector
- CLLS Health Care
- PERF Technology
- Exchange
- CLLS Nasdaq
- PERF Nasdaq
- Market Cap
- CLLS 148.1M
- PERF 166.0M
- IPO Year
- CLLS 2007
- PERF N/A
- Fundamental
- Price
- CLLS $1.45
- PERF $1.61
- Analyst Decision
- CLLS Buy
- PERF Buy
- Analyst Count
- CLLS 3
- PERF 1
- Target Price
- CLLS $7.00
- PERF $5.00
- AVG Volume (30 Days)
- CLLS 120.5K
- PERF 84.4K
- Earning Date
- CLLS 05-27-2025
- PERF 04-28-2025
- Dividend Yield
- CLLS N/A
- PERF N/A
- EPS Growth
- CLLS N/A
- PERF 7.43
- EPS
- CLLS N/A
- PERF 0.05
- Revenue
- CLLS $49,217,000.00
- PERF $60,202,000.00
- Revenue This Year
- CLLS $1.26
- PERF $16.02
- Revenue Next Year
- CLLS N/A
- PERF $14.43
- P/E Ratio
- CLLS N/A
- PERF $32.66
- Revenue Growth
- CLLS 435.38
- PERF 12.52
- 52 Week Low
- CLLS $1.10
- PERF $1.52
- 52 Week High
- CLLS $3.38
- PERF $3.44
- Technical
- Relative Strength Index (RSI)
- CLLS 60.38
- PERF 40.76
- Support Level
- CLLS $1.40
- PERF $1.56
- Resistance Level
- CLLS $1.56
- PERF $1.72
- Average True Range (ATR)
- CLLS 0.09
- PERF 0.13
- MACD
- CLLS 0.03
- PERF 0.00
- Stochastic Oscillator
- CLLS 76.09
- PERF 27.78
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.